JP2022549085A5 - - Google Patents
Info
- Publication number
- JP2022549085A5 JP2022549085A5 JP2022516290A JP2022516290A JP2022549085A5 JP 2022549085 A5 JP2022549085 A5 JP 2022549085A5 JP 2022516290 A JP2022516290 A JP 2022516290A JP 2022516290 A JP2022516290 A JP 2022516290A JP 2022549085 A5 JP2022549085 A5 JP 2022549085A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- rrm
- protein
- amino acid
- acid substitution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962902275P | 2019-09-18 | 2019-09-18 | |
| US62/902,275 | 2019-09-18 | ||
| PCT/US2020/051156 WO2021055530A1 (en) | 2019-09-18 | 2020-09-17 | Protein tag to induce ligand dependent degradation of protein/protein-fusions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022549085A JP2022549085A (ja) | 2022-11-24 |
| JP2022549085A5 true JP2022549085A5 (enExample) | 2023-09-26 |
Family
ID=74883712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516290A Pending JP2022549085A (ja) | 2019-09-18 | 2020-09-17 | タンパク質／タンパク質融合のリガンド依存性分解を誘導するためのタンパク質タグ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12428459B2 (enExample) |
| EP (1) | EP4031163A4 (enExample) |
| JP (1) | JP2022549085A (enExample) |
| AU (1) | AU2020351159A1 (enExample) |
| CA (1) | CA3150308A1 (enExample) |
| WO (1) | WO2021055530A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2922554T3 (pl) * | 2012-11-26 | 2022-06-20 | Modernatx, Inc. | Na zmodyfikowany na końcach |
| US10550379B2 (en) | 2015-06-29 | 2020-02-04 | The Board Of Trustees Of The Leland Stanford Junior University | Degron fusion constructs and methods for controlling protein production |
| CN109715808A (zh) * | 2016-04-15 | 2019-05-03 | 诺华股份有限公司 | 用于选择性蛋白质表达的组合物和方法 |
| US11807606B2 (en) * | 2018-01-25 | 2023-11-07 | Dana-Farber Cancer Institute, Inc. | Sulfonamide derivatives for protein degradation |
-
2020
- 2020-09-17 EP EP20866708.9A patent/EP4031163A4/en active Pending
- 2020-09-17 JP JP2022516290A patent/JP2022549085A/ja active Pending
- 2020-09-17 AU AU2020351159A patent/AU2020351159A1/en not_active Abandoned
- 2020-09-17 WO PCT/US2020/051156 patent/WO2021055530A1/en not_active Ceased
- 2020-09-17 CA CA3150308A patent/CA3150308A1/en active Pending
- 2020-09-17 US US17/642,874 patent/US12428459B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7275043B2 (ja) | 増大したｈＡＴファミリートランスポゾン媒介遺伝子導入ならびに関連する組成物、システムおよび方法 | |
| CN108430456B (zh) | 癌症疫苗 | |
| JP7053053B2 (ja) | 初代細胞のためのトランスポゾンに基づく転移システム | |
| Dodd et al. | Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies: R. Dodd et al. | |
| JP7221049B2 (ja) | レンチウイルス調製物の安定化のための緩衝液 | |
| JP2010516758A5 (enExample) | ||
| JP2023521663A5 (enExample) | ||
| WO2020002525A1 (en) | Novel lassa virus rna molecules and compositions for vaccination | |
| JP2023546158A5 (enExample) | ||
| JP2019517267A5 (enExample) | ||
| EP3601367A1 (en) | "chimeric molecules and uses thereof" | |
| JP2019521659A5 (enExample) | ||
| KR20160067219A (ko) | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 | |
| US20230059921A1 (en) | Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents | |
| CA3169228A1 (en) | Artificial synapses | |
| KR20180092989A (ko) | 트랜스포존 시스템, 이를 포함한 키트, 및 이들의 용도 | |
| US20250073350A1 (en) | Compositions and methods for delivering cargo to a target cell | |
| CN114945666A (zh) | 用于rna分子高效重组的组合物和方法 | |
| WO2023242425A1 (en) | Compositions and methods for circular rna affinity purification | |
| JP6618360B2 (ja) | 薬物送達タンパク質の輸送向上変異体の単離 | |
| WO2024148233A1 (en) | Agonist extracellular vesicles | |
| JP2022549085A5 (enExample) | ||
| JP7644429B2 (ja) | 細胞透過性トランスポザーゼ | |
| CN101087885A (zh) | 编码冠状病毒样颗粒之表达载体 | |
| WO2023215699A1 (en) | Multivalent display on enveloped particles with human oligomerization domains |